Original Research

Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2− Advanced Breast Cancer: A Nationwide Real-World Experience

Boér K, Rubovszky G, Rokszin G, Abonyi-Tóth Z, Földesi C, Dank M

OncoTargets and Therapy 2021, 14:3971-3981

Published Date: 1 July 2021